スタッフ ログイン
Japanese |
English
ご質問・ご要望
一覧
検索
生物種別閲覧
登録
統計情報
検索
ホーム
一覧
論文
特許
論文 - 一覧
«
»
10 Hits
検索条件 : 絞込み (MeSH = Pyrimidines / therapeutic use*)
生物種
リソース名
RRC ID
タイトル
ジャーナル
公開日
外部リンク
ヒト・動物細胞
HS-Sch-2(RCB2230)
75809
Appropriate modulation of autophagy sensitizes malignant peripheral nerve sheath tumor cells to treatment with imatinib mesylate.
J Pediatr Hematol Oncol
2014-4-1
Pubmed
Full text
ヒト・動物細胞
Ba/F3(RCB0805)
69464
Clinical Acquired Resistance to KRAS
G12C
Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation.
Cancer Discov
2021-8-1
Pubmed
Full text
ヒト・動物細胞
A549
,
RERF-LC-AI(RCB0444)
,
RERF-LC-KJ(RCB1313)
68851
Tofacitinib overcomes an IFNγ-induced decrease in NK cell-mediated cytotoxicity via the regulation of immune-related molecules in LC-2/ad.
Thorac Cancer
2021-3-1
Pubmed
Full text
ヒト・動物細胞
OP9(RCB1124)
68726
Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence.
Cancer Cell
2013-3-18
Pubmed
Full text
ヒト・動物細胞
DT40(RCB1464)
67556
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation.
Blood
2015-7-2
Pubmed
Full text
ゼブラフィッシュ
Tg(cmlc2:mRFP)ko07
66018
Identification of Potent
In Vivo
Autotaxin Inhibitors that Bind to Both Hydrophobic Pockets and Channels in the Catalytic Domain.
J Med Chem
2020-3-26
Pubmed
Full text
ヒト・動物細胞
KP4(RCB1005)
65155
First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors.
Clin Cancer Res
2020-3-15
Pubmed
Full text
ヒト・動物細胞
HGC-27(RCB0500)
,
GT3TKB(RCB0885)
61202
A novel carbazole topoisomerase II poison, ER-37328: potent tumoricidal activity against human solid tumors in vitro and in vivo.
Cancer Sci
2003-1-1
Pubmed
Full text
ヒト・動物細胞
MCF7(RCB1904)
,
L929
58712
GANT61 and curcumin-loaded PLGA nanoparticles for GLI1 and PI3K/Akt-mediated inhibition in breast adenocarcinoma.
Nanotechnology
2020-5-1
Pubmed
Full text
ヒト・動物細胞
HS-SY-II(RCB2231)
52223
Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma.
BMC Cancer
2017-5-16
Pubmed
Full text